Search

everythinglearnresearchcommunity

for

Search:↓

Hair analysis can help diagnose adrenal disorders non-invasively.

Ashwagandha may help reduce symptoms of adrenal hyperplasia.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Auriculotherapy and Aslagh capsules are as effective as metformin for treating PCOS symptoms, with auriculotherapy slightly better for reducing hair growth.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Dermatological conditions are complex and treatments often have mixed results.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

The document's conclusion cannot be provided because the document is not accessible or understandable.